Public Company News

Lunit to Present AI-Analyzed Immune Phenotype Study as Immunotherapy Response Predictor for Advanced Gastric Cancer at ESMO Congress 2024

* Lunit SCOPE IO® demonstrates potential to assess immune phenotype as an AI-powered biomarker for predicting efficacy of Nivolumab plus Chemotherapy in advanced gastric cancer, independent of PD-L1 status SEOUL, South Korea, Sept. 10, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provi...

2024-09-10 21:00 3082

LightInTheBox to Hold Annual General Meeting

SINGAPORE, Sept. 10, 2024 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), an apparel e-commerce retailer that ships products to consumers worldwide, announced that it will hold its annual general meeting of shareholders (the "AGM") at the 11th Floo...

2024-09-10 19:30 4603

I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at 2024 World Conference on Lung Cancer

- Pharmacokinetic/pharmacodynamic (PK/PD) modeling data from three Phase 1 studies providing dosing support for upcoming clinical trials - Exposure-Response (E-R) Analysis showed a positive correlation between uliledlimab concentration and ORR probability in mNSCLC patients - Randomized Phase 2 st...

2024-09-10 19:00 2036

ChipMOS REPORTS 15.4% YoY GROWTH IN AUGUST 2024 REVENUE, UP 2.5% MoM

HSINCHU, Sept. 10, 2024 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange:8150 and Nasdaq: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT")...

2024-09-10 18:00 2144

EZGO ANNOUNCES FINANCIAL RESULTS FOR THE SIX MONTHS ENDED MARCH 31, 2024

CHANGZHOU, China, Sept. 9, 2024 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or "we", "our", or the "Company"), a leading short-distance transportation solutions provider inChina, today announced its unaudited financial results for the six months endedMarch 31, 2024. Financial H...

2024-09-10 05:30 5042

WiMi Developed a Blockchain Empowered Asynchronous Federated Learning for Optimizing Model Training

BEIJING, Sept. 9, 2024 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it developed a blockchain-based asynchronous federated learning (BAFL). The framework combines blo...

2024-09-09 22:30 2955

SunCar Technology Group Inc. Schedules Earnings Conference Call for the First Half of Fiscal Year 2024 on Monday, September 16th at 8 a.m. ET

NEW YORK, Sept. 9, 2024 /PRNewswire/ -- SunCar Technology Group Inc. (the "Company" or "SunCar") (NASDAQ: SDA), an innovative leader in cloud-based B2B auto services and auto e-insurance inChina, will announce its financial results for the first half of fiscal year 2024 onMonday, September 16th b...

2024-09-09 21:46 3183

Xiao-I Corporation and the National Association of the Deaf Partner to Enhance Accessible Communication for Deaf Individuals with AI Technology

SHANGHAI, Sept. 9, 2024 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI) ("Xiao-I" or the "Company"), a leading artificial intelligence company, announces that it signed a strategic partnership with the National Association of the Deaf (the "NAD"), a premier American organization dedicated to im...

2024-09-09 21:45 3029

Caravelle International Group Announces Financial Results for Fiscal Year 2023

SINGAPORE, Sept. 9, 2024 /PRNewswire/ -- Caravelle International Group (Nasdaq: CACO), a global ocean technology company, today announced its audited financial results for the fiscal year endedOctober 31, 2023. Due to the overall environment of the shipping industry and increased operating cos...

2024-09-09 21:40 3853

IT Tech Packaging, Inc. to Hold Annual Meeting of Stockholders on October 31, 2024

BAODING, China, Sept. 9, 2024 /PRNewswire/ -- IT Tech Packaging, Inc. (NYSE American: ITP) ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products inNorth China, today announced that it has filed a definitive proxy statement for its 2024 annual...

2024-09-09 21:30 4243

JinkoSolar Earns RETC's "Overall Highest Achiever" Award for the Fifth Consecutive Year

SHANGRAO, China, Sept. 9, 2024 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. (the "Company," or "JinkoSolar") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that it has been recognized as an Overall Highest Achiever in Renewable Energy ...

2024-09-09 21:17 3579

Two Datasets Added to "J-Quants Pro," JPX's Most Convenient Financial Data Distribution Service for Corporate Users

TOKYO, Sept. 9, 2024 /PRNewswire/ -- The JPX Market Innovation & Research, Inc., a leading global provider ofJapan's financial market data, promptly added two data datasets to J-Quants Pro, a API/SFTP data distribution service covering most insightful data on Japanese financial markets for corpor...

2024-09-09 21:00 8015

SU Group and UrbanChain Agree to Jointly Develop Integrated AIoT Car Parking, Security and Access Control Solutions; SU Group Further Expands its Addressable Market

HONG KONG, Sept. 9, 2024 /PRNewswire/ -- SU Group Holdings Limited (Nasdaq: SUGP) ("SU Group" or the "Company"), an integrated security-related engineering services company inHong Kong, today announced it has entered into a joint development memorandum of understanding (the "MOU") with UrbanChain...

2024-09-09 21:00 3895

Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing

* Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine and improve cancer biomarker testing SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solution...

2024-09-09 21:00 2770

CLPS Incorporation Regains Compliance with Nasdaq Minimum Bid Price Requirement

HONG KONG, Sept. 9, 2024 /PRNewswire/ -- CLPS Incorporation (the "Company" or "CLPS") (Nasdaq: CLPS) today announced that it has received a written notice ("Notification") from the Nasdaq Stock Market LLC ("Nasdaq") informing that the Company has regained compliance with the Nasdaq's minimum bid ...

2024-09-09 20:30 3114

The First in the Global Lidar Industry: Hesai Obtained ISO 21448 Intended Functional Safety Process Certification

PALO ALTO, Calif., Sept. 9, 2024 /PRNewswire/ -- Hesai Technology, a global leader in the lidar industry, has successfully passed a rigorous audit by TÜV SÜD and obtained the ISO 21448 Safety of the Intended Functionality (SOTIF) certification based on ISO 26262 functional safety and a QMS framew...

2024-09-09 20:00 2862

Zhihu Inc. Commences Tender Offers to Buy Back Up to US$54.8 Million of Its Class A Ordinary Shares and American Depositary Shares

BEIJING, Sept. 9, 2024 /PRNewswire/ -- Zhihu Inc. (NYSE: ZH; HKEX: 2390) ("Zhihu" or the "Company"), a leading online content community inChina, today announced that it has commenced all cash tender offers (the "Offers") to buy back up to 46,921,448 Class A ordinary shares of the Company (includi...

2024-09-09 17:39 4010

Acer Announces August Consolidated Revenues at NT$22.82 Billion, Up 5.2% Year-on-year

TAIPEI, Sept. 9, 2024 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues for August atNT$22.82 billion with 5.24% growth year-on-year (YoY), achieving 14 consecutive months of YoY growth. Consolidated revenues for year-to-August reachedNT$172.28 billion with 14.8% growth Y...

2024-09-09 16:54 3350

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization

TAIPEI, Sept. 9, 2024 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (hereinafter referred to as "Formosa Pharma," 6838.TW) announced the successful first shipment tothe United States of its new ophthalmic drug, Clobetasol Propionate Ophthalmic Suspension, 0.05% (APP13007), manufactured by Bora P...

2024-09-09 15:00 2826

Senhwa Biosciences Presents Clinical Data Abstract on Pidnarulex at 2024 ESMO Congress

* The study involved end-stage oncology patients with no other suitable treatment options. * In this Phase Ib study, Pidnarulex (CX-5461) demonstrated acceptable clinical tolerability and showed preliminary signs of efficacy, even in patients who had previously failed treatment with PARP inhi...

2024-09-09 10:33 3271
1 ... 293294295296297298299 ... 750

Week's Top Stories